What Are Peptides? Therapeutic Uses, Mechanisms & Safety (2026 Guide)
A plain-language guide to peptide therapeutics - what they are, how clinicians use them, and how to think about safety, sourcing, and outcomes.
Peptides are short chains of amino acids—the same building blocks as proteins, just smaller—that bind specific cell-surface receptors to trigger targeted physiological signals like satiety, growth-hormone release, or tissue repair. Most therapeutic peptides are dispensed by Wells Pharmacy Network only after a licensed clinician evaluation; many are not FDA-approved as finished drug products.
What is a peptide and how does it work?
Therapeutic peptides bind to specific receptors on the surface of cells, triggering a cascade of downstream effects. Because each peptide is highly selective for its target, side effects tend to be more limited than with broad-spectrum small molecules. Most therapeutic peptides are administered subcutaneously because the GI tract would otherwise digest them.
How do clinicians use Peptides?
How clinicians prescribe them
Peptide protocols are typically cycled - a defined course of weeks or months, paired with labs, lifestyle inputs, and clinician check-ins. The goal is to nudge a system back into balance, not to override it indefinitely.
Sourcing and quality
Quality varies enormously across the peptide market. Regen Therapy works only with 503A and 503B compounding pharmacies that meet our purity, potency, and chain-of-custody requirements.
What to expect
Patient experience varies. Some adults inside a well-matched, clinician-directed protocol describe subtle, accumulating changes over the first several weeks; others do not. Lab markers and clinician check-ins are used to track response over time. No specific outcome is guaranteed.
What are Peptides studied for?
Different peptides are studied in different research areas. The categories below summarise where the published literature is most active.
Recovery and tissue repair
BPC-157, TB-500, and GHK-Cu are studied in preclinical models of tendon, ligament, and connective-tissue healing. Clinicians often consider them as adjuncts in protocols framed around orthopedic recovery.
Growth-hormone axis support
GHRH analogues (CJC-1295, Tesamorelin) and GHRPs (Ipamorelin, GHRP-2/6) are studied for their effect on endogenous pulsatile GH release. This is a different mechanism than administering exogenous GH.
Metabolic and body-composition research
MOTS-c and AOD-9604 are studied for their effects on mitochondrial signalling and adipose-tissue lipolysis without raising IGF-1 in the same way as full-length GH.
Cognitive and neuroprotective research
Semax, Selank, Cerebrolysin, and Dihexa are studied for neurotrophic and neuroprotective signalling in the literature, primarily in animal models and small clinical observations.
Which ingredients power Peptides protocols?
Wiki entries on individual ingredients used inside Peptides protocols.
Frequently asked questions about Peptides
Are therapeutic peptides FDA-approved?
Some peptides have FDA-approved finished drug products under labeled indications (e.g. Tesamorelin for HIV-associated lipodystrophy, semaglutide for type 2 diabetes and chronic weight management). Most peptides discussed in research literature are not FDA-approved as finished drug products and, when used clinically, are accessed via 503A or 503B compounding pharmacies after an individual clinician evaluation.
How do peptides differ from small-molecule drugs?
Peptides are short amino-acid chains that bind to specific cell-surface receptors. Small-molecule drugs are typically smaller, often cross the blood–brain barrier more readily, and frequently target intracellular enzymes. Because peptides are protein-based, they are usually given by subcutaneous injection rather than orally - the GI tract would otherwise digest them.
How are peptide protocols designed?
A clinician reviews intake, history, and labs and decides whether a peptide is appropriate, which compound to consider, and at what dose, frequency, and cycle length. The clinician also defines the monitoring plan: which labs are repeated, how often, and what markers count as a stop signal.
What are the most common side effects?
Side effects depend on the specific peptide. Common categories include local injection-site reactions, transient water retention with GH-axis peptides, and flushing with histaminergic peptides such as PT-141. Any reproducibly tolerated protocol is the result of clinician-directed dose titration.
Is purity a real concern?
Yes. The peptide market includes a wide range of grey-market vendors with no enforceable purity standard. Regen Therapy works only with 503A and 503B compounding pharmacies that meet our purity, potency, and chain-of-custody requirements, and the dispensing pharmacy is named for every prescription.
Can I combine peptides?
Combination protocols (e.g. CJC-1295 with Ipamorelin, BPC-157 with TB-500) are common in the literature, but combinations should always be designed by the prescribing clinician. Stacking peptides without supervision risks unbalancing the same axes the protocol is meant to support.
Where can I read the source research?
- Sikiric P et al. - BPC-157 in tendon, ligament, and gut research (multiple reviews)
- Falutz J et al., NEJM 2007 - Tesamorelin reduces visceral adipose tissue in HIV-associated lipodystrophy
- Teichman SL et al., J Clin Endocrinol Metab 2006 - CJC-1295 sustained GH/IGF-1 elevation
- Lee C et al., Cell Metab 2015 - MOTS-c regulates insulin sensitivity and metabolic homeostasis
- FDA - Compounding and the FDA: Questions and answers (503A vs. 503B)
Ready to look at protocols?
Browse the catalog or start a clinician evaluation. Every prescription is reviewed by a licensed clinician.
Browse peptide protocols →